Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) Asset Utilization Ratio: 2013-2025

Historic Asset Utilization Ratio for Fortress Biotech (FBIO) over the last 12 years, with Sep 2025 value amounting to 0.37.

  • Fortress Biotech's Asset Utilization Ratio fell 20.33% to 0.37 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.37, marking a year-over-year decrease of 20.33%. This contributed to the annual value of 0.37 for FY2024, which is 1.10% up from last year.
  • Latest data reveals that Fortress Biotech reported Asset Utilization Ratio of 0.37 as of Q3 2025, which was up 4.04% from 0.35 recorded in Q2 2025.
  • Fortress Biotech's Asset Utilization Ratio's 5-year high stood at 0.53 during Q2 2024, with a 5-year trough of 0.12 in Q1 2021.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.43 (2024), whereas its average is 0.41.
  • Per our database at Business Quant, Fortress Biotech's Asset Utilization Ratio crashed by 35.42% in 2021 and then surged by 124.76% in 2024.
  • Over the past 5 years, Fortress Biotech's Asset Utilization Ratio (Quarterly) stood at 0.17 in 2021, then spiked by 42.10% to 0.24 in 2022, then surged by 118.62% to 0.53 in 2023, then decreased by 19.99% to 0.43 in 2024, then declined by 20.33% to 0.37 in 2025.
  • Its last three reported values are 0.37 in Q3 2025, 0.35 for Q2 2025, and 0.36 during Q1 2025.